Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Jennifer L. Geurts MS, CGC

Director, Assistant Professor

Institution: Medical College of Wisconsin
Department: Institute for Health and Equity
Division: Administration
Program: Administration


Publications (9)

  • Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer. (Uyar D, Neary J, Monroe A, Nugent M, Simpson P, Geurts JL) Gynecol Oncol 2018 06;149(3):565-569 PMID: 29653687 SCOPUS ID: 2-s2.0-85045079578 04/15/2018       6 Citations
  • Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. (Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL) Am J Surg 2016 Oct;212(4):660-669 PMID: 27649974 SCOPUS ID: 2-s2.0-84991709374 09/22/2016       57 Citations
  • Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency. (Sachs Z, Been RA, DeCoursin KJ, Nguyen HT, Mohd Hassan NA, Noble-Orcutt KE, Eckfeldt CE, Pomeroy EJ, Diaz-Flores E, Geurts JL, Diers MD, Hasz DE, Morgan KJ, MacMillan ML, Shannon KM, Largaespada DA, Wiesner SM) Haematologica 2016 10;101(10):1190-1199 PMID: 27418650 PMCID: PMC5046648 07/16/2016       7 Citations
  • Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines. (Marcus RK, Geurts JL, Grzybowski JA, Turaga KK, Clark Gamblin T, Strong KA, Johnston FM) Fam Cancer 2015 Dec;14(4):641-9 PMID: 26108897 SCOPUS ID: 2-s2.0-84946479011 06/26/2015       6 Citations
  • Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype. (Wiesner SM, Geurts JL, Diers MD, Bergerson RJ, Hasz DE, Morgan KJ, Largaespada DA) Am J Hematol 2011 Jul;86(7):579-85 PMID: 21681782 PMCID: PMC3506005 06/18/2011       4 Citations
  • Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice. (Kim A, Morgan K, Hasz DE, Wiesner SM, Lauchle JO, Geurts JL, Diers MD, Le DT, Kogan SC, Parada LF, Shannon K, Largaespada DA) Blood 2007 Feb 15;109(4):1687-91 PMID: 17090653 PMCID: PMC1794059 11/09/2006       20 Citations
  • Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemers. (Geurts AM, Collier LS, Geurts JL, Oseth LL, Bell ML, Mu D, Lucito R, Godbout SA, Green LE, Lowe SW, Hirsch BA, Leinwand LA, Largaespada DA) PLoS Genet 2006 Sep 29;2(9):e156 PMID: 17009875 PMCID: PMC1584263 SCOPUS ID: 2-s2.0-33749416026 10/03/2006       70 Citations
  • RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues. (Wilber A, Frandsen JL, Geurts JL, Largaespada DA, Hackett PB, McIvor RS) Mol Ther 2006 Mar;13(3):625-30 PMID: 16368272 12/22/2005       91 Citations
  • Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression. (Score PR, Belur LR, Frandsen JL, Geurts JL, Yamaguchi T, Somia NV, Hackett PB, Largaespada DA, McIvor RS) Mol Ther 2006 Mar;13(3):617-24 PMID: 16356773 12/17/2005       26 Citations
  • Last update: 01/14/2020
    jenkins-FCD Prod-461 7d7c6113fc1a2757d2947d29fae5861c878125ab